Attached files

file filename
EX-99.1 - EX-99.1 PRESS RELEASE DATED JANUARY 12, 2016 - NOVELION THERAPEUTICS INC.a16-1804_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): January 12, 2016 (January 8, 2016)

 

QLT Inc.

(Exact Name of Registrant as specified in its charter)

 

British Columbia, Canada

 

000-17082

 

N/A

(State or Other Jurisdiction of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

887 Great Northern Way, Suite 250, Vancouver, B.C.

Canada, V5T 4T5

(Address of principal executive offices)

 

Registrant’s telephone number, including area code:  (604) 707-7000

 

Not Applicable

(Registrant’s name or former address, if change since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07.  Submission of Matters to a Vote of Security Holders

 

On January 8, 2016, QLT Inc. (“QLT” or the “Company”) held its Annual General Meeting of shareholders in Vancouver, British Columbia (the “AGM”).  At the AGM, QLT shareholders voted to elect directors.  The final voting results with respect to each matter are set forth below.

 

Proposal 1.  Each of the six nominees to the Board of Directors was elected at the AGM, to hold office until the Company’s next annual meeting of shareholders or until his successor is duly elected, unless he resigns earlier.

 

DIRECTORS NOMINATED

 

FOR

 

WITHHELD

 

BROKER NON-VOTES

 

Jason M. Aryeh

 

30,993,845

 

3,321,352

 

4,612,849

 

Dr. Geoffrey F. Cox PhD

 

31,208,904

 

3,106,293

 

4,612,849

 

Dr. John W. Kozarich PhD

 

31,223,945

 

3,091,252

 

4,612,849

 

Jeffrey A. Meckler

 

30,811,599

 

3,503,598

 

4,612,849

 

Dr. Stephen L. Sabba MD

 

31,202,781

 

3,112,416

 

4,612,849

 

John C. Thomas Jr.

 

30,971,911

 

3,343,286

 

4,612,849

 

 

Proposal 2.  At the AGM, the shareholders approved the proposal to appoint Deloitte LLP as the Company’s independent auditors for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors.

 

FOR

 

WITHHELD

 

35,600,797

 

3,327,249

 

 

Proposal 3.  At the AGM, the shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers.

 

FOR

 

AGAINST

 

WITHHELD

 

BROKER NON-VOTES

 

30,781,499

 

353,116

 

3,180,580

 

4,612,851

 

 

2



 

Item 8.01. Other Events.

 

On January 12, 2016, QLT Inc. issued a press release announcing the results from its AGM. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Number

 

Description

99.1

 

Press Release dated January 12, 2016

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

QLT INC.

 

 

 

 

 

 

 

By:

/s/ W. Glen Ibbott

 

Name:

W. Glen Ibbott

 

Title:

Chief Financial Officer

 

 

 

Date:      January 12, 2016

 

4



 

Exhibit Index

 

Number

 

Description

 

99.1

 

Press Release dated January 12, 2016

 

 

5